# A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis (AD)

> **NCT06756126** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Akeso** · enrollment: 24 (estimated)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** AK120

## Key facts

- **NCT ID:** NCT06756126
- **Lead sponsor:** Akeso
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-30
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-01-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06756126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06756126, "A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis (AD)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06756126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*